CAPZB overexpression has indeed been reported in epithelioid sarcoma tissue specimens, where it increased cell growth and motility [82], while CAPZA1 could regulate cell growth, invasion, and EMT markers in various human tumors, representing an unfavorable prognostic marker in gastric and lung cancers [83,84,85]. This evidence concerns the gene CAPZB and lung carcinoma.